Each of these experimental vaccines has already shown promise in smaller trials designed to flag any serious safety concerns and show whether candidates can spur some response from the immune system. Early safety data is key; unlike drugs, vaccines are typically given to relatively healthy people and shouldn’t create severe risks.from Industry-Economic Times
Read The Rest:economictimes...
